In 2024, Elevance Health, the parent company of CarelonRx, acquired Paragon Healthcare, Inc., a leader in life-saving and life-giving infusible and injectable therapies. Now part of CarelonRx, Paragon Healthcare strengthens our ability to offer affordable and convenient access to specialty medications for those with chronic and complex illnesses like cancer, multiple sclerosis, and others.
What is infusion therapy?
Infusion therapy delivers medication directly into a patient's bloodstream through a needle or catheter. It's essential for individuals who need treatments that can't be taken orally, require higher doses, or have conditions that make oral treatments ineffective.
Carelon recently published an article on some of the top benefits of an ambulatory infusion center (AIC), such as:
- Cost efficiency. Receiving infusions in a hospital setting can be prohibitively expensive. The shift to anAIC can significantly reduce out-of-pocket expenses for plan members, without compromising quality.
- Enhanced access and outcomes. Ambulatory centers offer more consistent scheduling than hospitals, reducing disruptions in care. Members can keep their treatment plans on track, which helps improve health outcomes.
- Improved experiences. For many, infusion treatments are a regular fact of life. AICs provide an environment for quality care by caring professionals, supporting members who are also seeking the most cost-effective and convenient places for treatment.
Read the full article on Carelon.com: Expanding Affordable Access to Infused Medications
You may also be interested in:
DrugInsights update Q3 2024 - clinical report
Emergency preparedness and specialty medication delivery
